United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

chiesi ltd - beclometasone dipropionate; formoterol fumarate dihydrate - inhalation powder - 100microgram/1dose ; 6microgram/1dose

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

chiesi ltd - formoterol fumarate dihydrate; beclometasone dipropionate - inhalation powder - 6microgram/1dose ; 200microgram/1dose

Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - beclometasone dipropionate anhydrous (micronized); formoterol fumarate dihydrate (micronized) - powder, metered - beclometasone dipropionate anhydrous (micronized) 100mcg/dose; formoterol fumarate dihydrate (micronized) 6mcg/dose

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate; formoterol fumarate dihydrate - inhalation powder - 200 micrograms/ 12 microgram(s) - formoterol and beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - inhalation powder - 100/6 mcg/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi limited - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - powder for inhalation - 200/6 mcg/acutuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - inhalation powder - 200/6 mcg/acutuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and beclometasone

Israel - English - Ministry of Health

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - pressurised solution - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.copd :symptomatic treatment of patients with severe copd (fev1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.

United Kingdom - English - myHealthbox

chiesi limited - beclometasone dipropionate, formoterol fumarate dihydrate. - pressurised inhalation solution. - 200/6 micrograms/metered dose - drugs for obstructive airway diseases; adrenergics, inhalants - fostair is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists. fostair is indicated in adults.

United Kingdom - English - myHealthbox

chiesi gmbh - dipropionate anhydrous, formoterol fumarate dihydrate. - inhalation powder. - 200 micrograms/6 micrograms for metered dose - rugs for obstructive airway diseases; adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics. - fostair nexthaler is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or - patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists. fostair nexthaler is indicated in adults. note: there are no relevant clinical data on the use of fostair nexthaler for the treatment of acute asthma attacks.